INDOLE DERIVATIVES AS PPAR MODULATORS

Details for Australian Patent Application No. 2003300131 (hide)

Owner ELI LILLY AND COMPANY

Inventors CONNER, Scott, Eugene; KNOBELSDORG, James, Allen; MANTLO, Nathan, Bryan; MAYHUGH, Daniel, Ray; WANG, Xiaodong; ZHU, Guoxin; SCHKERYANTZ, Jeffrey, Michael; MICHELLYS, Pierre-Yves

Pub. Number AU-A-2003300131

PCT Number PCT/US2003/0416

PCT Pub. Number WO2004/092131

Priority 60/438,541 06.01.03 US

Filing date 31 December 2003

Wipo publication date 4 November 2004

International Classifications

C07D 209/08 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/5377

A61P 003/10 Drugs for disorders of the metabolism

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/404

A61K 031/422 - not condensed and containing further heterocyclic rings

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/438,541 06.01.03 US

9 December 2004 Application Open to Public Inspection

  Published as AU-A-2003300131

1 September 2005 Corrigenda

  Applications OPI - Name Index Under the name ELI LILLY AND COMPANY, Application No. 2003300131, under INID (71) correct the name to read LIGAND PHARMACEUTICALS, INC.; ELI LILLY AND COMPANY

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300132-SUBSTITUTED C-IMIDAZO(1,2-A)PYRIDIN-3-YL-METHYLA MINES

2003300130-Speech recognition method